skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of cancer protein biomarkers using proteomic techniques

Abstract

The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.

Inventors:
; ;
Issue Date:
Research Org.:
Yale Univ., New Haven, CT (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1172149
Patent Number(s):
8,975,379
Application Number:
12/644,677
Assignee:
Yale University (New Haven, CT)
DOE Contract Number:  
FG02-ER63462
Resource Type:
Patent
Resource Relation:
Patent File Date: 2009 Dec 22
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Mor, Gil G, Ward, David C, and Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States: N. p., 2015. Web.
Mor, Gil G, Ward, David C, & Bray-Ward, Patricia. Identification of cancer protein biomarkers using proteomic techniques. United States.
Mor, Gil G, Ward, David C, and Bray-Ward, Patricia. Tue . "Identification of cancer protein biomarkers using proteomic techniques". United States. https://www.osti.gov/servlets/purl/1172149.
@article{osti_1172149,
title = {Identification of cancer protein biomarkers using proteomic techniques},
author = {Mor, Gil G and Ward, David C and Bray-Ward, Patricia},
abstractNote = {The claimed invention describes methods to diagnose or aid in the diagnosis of cancer. The claimed methods are based on the identification of biomarkers which are particularly well suited to discriminate between cancer subjects and healthy subjects. These biomarkers were identified using a unique and novel screening method described herein. The biomarkers identified herein can also be used in the prognosis and monitoring of cancer. The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2015},
month = {3}
}

Patent:

Save / Share:

Works referenced in this record:

Circulating levels of insulin-like growth factor-II and IGF-binding protein 3 in cervical cancer
journal, December 2003

  • Mathur, Subbi P.; Mathur, Rajesh S.; Underwood, Paul B.
  • Gynecologic Oncology, Vol. 91, Issue 3, p. 486-493
  • DOI: 10.1016/j.ygyno.2003.08.023

Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
journal, April 2002

  • Kim, Jae-Hoon; Skates, Steven J.; Uede, Toshimitsu
  • JAMA, Vol. 287, Issue 13, p. 1671-1679
  • DOI: 10.1001/jama.287.13.1671

Prolactin as a tumour marker in cancer of the cervix
journal, January 1998

  • G. Perumal, J. Moodley, R. J. Pegor, B.
  • Journal of Obstetrics and Gynaecology, Vol. 18, Issue 3
  • DOI: 10.1080/01443619867452

Serum Vascular Endothelial Growth Factor and Serum Leptin in Patients with Cervical Cancer
journal, April 2002

  • Lebrecht, Antje; Ludwig, Elisabeth; Huber, Ambros
  • Gynecologic Oncology, Vol. 85, Issue 1
  • DOI: 10.1006/gyno.2001.6517

Leptin expression in colorectal and breast cancer patients.
journal, April 2000

  • Tessitore, L.; Vizio, B.; Jenkins, O.
  • International Journal of Molecular Medicine
  • DOI: 10.3892/ijmm.5.4.421

Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression
journal, August 2000


Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer
journal, May 2004


Expression of Leptin Receptors and Potential Effects of Leptin on the Cell Growth and Activation of Mitogen-Activated Protein Kinases in Ovarian Cancer Cells
journal, January 2005

  • Choi, Jung-Hye; Park, Se-Hyung; Leung, Peter C. K.
  • The Journal of Clinical Endocrinology & Metabolism, Vol. 90, Issue 1
  • DOI: 10.1210/jc.2004-0297

Fasting Ghrelin Levels in Physically Active Women: Relationship with Menstrual Disturbances and Metabolic Hormones
journal, July 2004

  • De Souza, Mary Jane; Leidy, Heather J.; O’Donnell, Emma
  • The Journal of Clinical Endocrinology & Metabolism, Vol. 89, Issue 7
  • DOI: 10.1210/jc.2003-032007

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells
journal, July 2004

  • Dixit, Vishwa Deep; Schaffer, Eric M.; Pyle, Robert S.
  • Journal of Clinical Investigation, Vol. 114, Issue 1
  • DOI: 10.1172/JCI200421134

The Functional and Clinical Roles of Osteopontin in Cancer and Metastasis
journal, November 2001


Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian Cancer
journal, April 2005


Multiple Kinase Cascades Mediate Prolactin Signals to Activating Protein-1 in Breast Cancer Cells
journal, December 2004

  • Gutzman, Jennifer H.; Rugowski, Debra E.; Schroeder, Matthew D.
  • Molecular Endocrinology, Vol. 18, Issue 12
  • DOI: 10.1210/me.2004-0187

Enhanced Expression of Leptin and Leptin Receptor (OB-R) in Human Breast Cancer
journal, July 2004


Progress and Challenges in Screening for Early Detection of Ovarian Cancer
journal, February 2004


Use of serum prolactin for monitoring the therapeutic response in ovarian malignancy
journal, September 1991

  • Jha, P.; Farooq, A.; Rao, D. L.
  • International Journal of Gynecology & Obstetrics, Vol. 36, Issue 1, p. 33-38
  • DOI: 10.1016/0020-7292(91)90175-5

Leptin directly stimulates aromatase activity in human luteinized granulosa cells
journal, August 1999


Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma
journal, April 2003


Prolactin increases HO-1 expression and induces VEGF production in human macrophages
journal, January 2004

  • Malaguarnera, L.; Imbesi, R. M.; Scuto, A.
  • Journal of Cellular Biochemistry, Vol. 93, Issue 1
  • DOI: 10.1002/jcb.20167

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
journal, October 2004


Ovarian cancer screening
journal, August 2004


Serum protein markers for early detection of ovarian cancer
journal, May 2005

  • Mor, G.; Visintin, I.; Lai, Y.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 21, p. 7677-7682
  • DOI: 10.1073/pnas.0502178102

Therapeutic Implications of Immune-endocrine Interactions in the Critically Ill Patients
journal, June 2004

  • Oberbeck, Reiner
  • Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Issue 2
  • DOI: 10.2174/1568008043339884

Prolactin acts as a potent survival factor for human breast cancer cell lines
journal, June 2004

  • Perks, C. M.; Keith, A. J.; Goodhew, K. L.
  • British Journal of Cancer, Vol. 91, Issue 2
  • DOI: 10.1038/sj.bjc.6601947

Prolactin as a tumour marker in cancer of the cervix
journal, January 1998

  • G. Perumal, J. Moodley, R. J. Pegor, B.
  • Journal of Obstetrics and Gynaecology, Vol. 18, Issue 3
  • DOI: 10.1080/01443619867452

Use of Proteomic Patterns in Serum to Identify Ovarian Cancer
journal, January 2002


Serum tumor markers in colorectal cancer staging, grading, and follow-up
journal, August 1996


Role of osteopontin in tumour progression
journal, April 2004


Obesity, adipocytokines, and insulin resistance in breast cancer
journal, August 2004


Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy
journal, August 2004

  • Santin, Alessandro D.; Zhan, Fenghuang; Bellone, Stefania
  • International Journal of Cancer, Vol. 112, Issue 1
  • DOI: 10.1002/ijc.20408

Osteopontin as an Adjunct to CA125 in Detecting Recurrent Ovarian Cancer
journal, May 2004


Multiplexed protein profiling on microarrays by rolling-circle amplification
journal, April 2002

  • Schweitzer, Barry; Roberts, Scott; Grimwade, Brian
  • Nature Biotechnology, Vol. 20, Issue 4, p. 359-365
  • DOI: 10.1038/nbt0402-359

Cancer screening in a high risk population: a clinical trial
journal, April 2001


Leptin expression in colorectal and breast cancer patients.
journal, April 2000

  • Tessitore, L.; Vizio, B.; Jenkins, O.
  • International Journal of Molecular Medicine
  • DOI: 10.3892/ijmm.5.4.421

Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer
journal, September 2004


Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine
journal, July 2004

  • Unni, Emmanual; Kittrell, Frances S.; Singh, Uma
  • Breast Cancer Research, Vol. 6, Issue 5
  • DOI: 10.1186/bcr914

Ovarian cancer screening
journal, August 2003

  • Urban, Nicole; McIntosh, Martin W.; Andersen, Marin (Robyn)
  • Hematology/Oncology Clinics of North America, Vol. 17, Issue 4, p. 989-1005
  • DOI: 10.1016/S0889-8588(03)00063-7

Diagnostic Markers for Early Detection of Ovarian Cancer
journal, February 2008


The role of Osteopontin in tumor metastasis
journal, October 2004


The metastasis gene osteopontin: a candidate target for cancer therapy
journal, December 2001


Elevation of Multiple Serum Markers in Patients With Stage I Ovarian Cancer
journal, November 1993

  • Woolas, R. P.; Xu, F. -J.; Jacabs, I. J.
  • JNCI Journal of the National Cancer Institute, Vol. 85, Issue 21
  • DOI: 10.1093/jnci/85.21.1748

Differential Gene Expression in Chemically Induced Mouse Lung Adenomas
journal, January 2003


Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level
journal, October 1998

  • Yoshida, Masumi; Koshiyama, Masafumi; Konishi, Mitsunaga
  • European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 81, Issue 1, p. 123-128
  • DOI: 10.1016/S0301-2115(98)00162-6

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
journal, August 2004